Skip to main content
. 2017 Apr 23;8:60–72. doi: 10.1016/j.dadm.2017.04.003

Table 2.

Cross-sectional comparisons across three clinical classifications namely HC, MCI, and AD

Time point Biomarker Mean (SD)
HC/MCI/AD
HC versus MCI
HC versus AD
MCI versus AD
HC MCI AD Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Baseline TPO 453.72 (128.25) 486.4 (133.06) 498.25 (151.94) 0.0012 0.0356 0.0563 0.2509 0.0039 0.0502 0.5974 0.5387
IL-18 201.62 (78.55) 202.11 (99.01) 205.86 (102.95) 0.9283 0.8336 0.8567 0.7213 0.9954 0.8138 0.8969 0.5814
FABP3 6417.9 (2498.74) 7664.95 (2577.08) 7707.77 (2993.31) 2.02E−08 0.3356 2.18E−05 0.1285 3.41E−06 0.8375 0.9936 0.4419
PPY 151.51 (123.25) 195.11 (190.74) 226.44 (153.94) 3.16E−05 0.1075 0.1249 0.9325 7.56E−06 0.037 0.0775 0.1454
I309 1.76 (0.89) 1.66 (0.66) 2.25 (1.43) 0.0015 0.2862 0.5181 0.117 1.13E−05 0.0167 0.001 0.0066
SAA 5,014,328.58 (12,441,294.73) 4,556,617.17 (5,400,336.74) 10,066,848.34 (25,001,707.84) 0.019 0.0582 0.2092 0.2693 0.0319 0.1127 0.6153 0.6228
CRP 2,623,075.41 (5,483,161.45) 2,105,933.51 (1,992,259.53) 2,764,309.64 (5,501,614.76) 0.1497 0.9508 0.905 0.5195 0.059 0.4626 0.1728 0.4252
sVCAM 412,578.76 (93,418.88) 443,844.82 (107,111.58) 464,594.39 (118,439.3) 7.59E−06 0.1634 0.012 0.3654 4.09E−05 0.0855 0.3422 0.7705
sICAM 258,715.61 (57,091.32) 274,167.46 (70,100.74) 275,757.24 (57,768.89) 0.0046 0.1765 0.0524 0.3084 0.0165 0.6791 0.8869 0.9136
A2M 1,747,511,738.03 (513,469,652) 1,855,714,846.34 (602,037,583.95) 1,893,399,396.14 (581,856,370.49) 0.0062 0.4693 0.1635 0.8476 0.0101 0.4797 0.5236 0.4959
B2M 2,302,005.26 (854,220.32) 2,564,836.72 (962,444.25) 2,600,875.68 (868,669.09) 6.45E−05 0.6796 0.0223 0.7112 0.0002 0.283 0.5081 0.975
fVII 855,774.28 (204,030.04) 879,676.06 (200,143.09) 870,519.29 (211,777.27) 0.33 0.4349 0.3435 0.3465 0.5341 0.8441 0.7428 0.6244
Adipo 72,058,918.21 (37,972,553.53) 85,795,000.94 (47,271,598.65) 91,367,246.13 (52,484,686.66) 9.37E−06 0.0461 0.0067 0.0898 9.60E−05 0.0402 0.5956 0.9282
ApoJ 34,840,490.7 (6,569,730.63) 36,905,488.48 (7,081,682.5) 38,901,971.01 (8,064,135.24) 2.70E−07 0.0003 0.0183 0.0875 4.31E−07 0.0004 0.1232 0.1435
18 months TPO 439.01 (124.56) 484.25 (130.48) 489.65 (168.28) 0.0005 0.0172 0.0176 0.0276 0.0034 0.0836 0.8974 0.4575
IL-18 197.31 (78.42) 202.49 (92.26) 201.59 (101.17) 0.9834 0.9396 0.8507 0.5852 0.9475 0.8877 0.86 0.4857
FABP3 6560.26 (2371.26) 7983.14 (2970.32) 7921.63 (3075.55) 3.03E−09 0.2022 0.0001 0.1219 5.15E−08 0.4821 0.8588 0.8237
PPY 160.98 (124.66) 164.33 (162.1) 231.27 (157.33) 3.65E−05 0.0443 0.4921 0.0557 1.44E−07 0.01 0.0002 0.0001
I309 1.82 (1.04) 1.72 (0.91) 2.25 (1.28) 0.0021 0.9447 0.369 0.0669 0.0001 0.1752 0.0028 0.0202
SAA 4,508,476.82 (10,011,818.68) 6,010,980.54 (13,928,739.6) 11,051,022.73 (26,601,726.7) 0.0049 0.0331 0.8312 0.8133 0.0007 0.007 0.0519 0.2179
CRP 2,324,026.89 (3,678,293.91) 3,244,249.76 (7,168,549.06) 3,750,314.02 (9,648,464.51) 0.2513 0.5808 0.8488 0.9327 0.2133 0.5945 0.5862 0.9336
sVCAM 413,866.28 (94,396.07) 451,372.28 (128,980.99) 461,761.39 (123,431.77) 3.82E−05 0.5612 0.0336 0.6051 0.0001 0.5823 0.5645 0.8394
sICAM 256,940.34 (63,741.88) 276,181.68 (81,976.23) 273,854.69 (65,996.05) 0.0086 0.629 0.07 0.3302 0.022 0.8845 0.8916 0.5686
A2M 1,799,156,641.14 (533,559,105.75) 1,818,415,510.22 (540,494,569.01) 1,966,783,241.78 (593,726,925.78) 0.0051 0.6885 0.7756 0.5794 0.002 0.4514 0.097 0.1402
B2M 2,380,739.82 (906,482.97) 2,586,551.41 (1,058,022.97) 2,792,433.32 (1,002,092.54) 2.00E−06 0.4936 0.1107 0.754 1.18E−06 0.1792 0.1148 0.3201
fVII 859,839.14 (217,735.63) 843,890.76 (211,518.29) 904,916.05 (221,993.04) 0.1079 0.094 0.636 0.9626 0.0399 0.275 0.0974 0.3038
Adipo 73,899,317.71 (40,137,703.56) 87,609,586.8 (51,060,964.01) 89,456,380.55 (47,630,520.81) 2.76E−05 0.0681 0.0197 0.0158 0.0001 0.0711 0.7607 0.399
ApoJ 35,076,852.22 (6,760,610.92) 36,935,240.02 (7,250,908.7) 39,828,311.84 (8,650,920.67) 3.59E−09 0.0003 0.0635 0.1112 7.05E−10 0.0004 0.0451 0.523
36 months TPO 437.79 (119.73) 463.2 (105.38) 478.3 (153.32) 0.0012 0.1789 0.1478 0.6842 0.0023 0.4755 0.5599 0.3682
IL-18 194.68 (77.96) 199.61 (97.69) 194.57 (94.75) 0.7527 0.876 0.8155 0.5699 0.6417 0.7694 0.6611 0.4462
FABP3 6953.36 (2904.37) 7988.9 (3178.54) 8026.43 (3242.37) 1.14E−05 0.6319 0.0096 0.7746 0.0001 0.4757 0.8671 0.5791
PPY 162.11 (118.95) 172.88 (151.87) 228.83 (165.22) 0.0004 0.2124 0.7835 0.1079 2.56E−05 0.0651 0.0111 0.0119
I309 1.91 (1.12) 1.72 (0.89) 2.29 (1.41) 0.0054 0.5469 0.1233 0.0118 0.0001 0.5706 0.0007 0.0266
SAA 6,591,850.97 (20,102,101.96) 6,152,281.83 (9,696,054.8) 11,689,850.22 (28,348,629.61) 0.0022 0.0106 0.3237 0.1837 0.0018 0.016 0.3668 0.8677
CRP 2,815,106.56 (6,320,376.91) 2,580,568.27 (3,838,300.23) 4,135,642.49 (10,667,549.77) 0.2797 0.9952 0.6139 0.9748 0.3071 0.9831 0.8702 0.8581
sVCAM 427,124.68 (103,231.67) 458,365.34 (108,775.08) 493,257.79 (138,934.86) 1.67E−07 0.0134 0.0351 0.2046 1.60E−07 0.0136 0.1919 0.6776
sICAM 264,728.18 (65,030.13) 273,235.93 (73,269.22) 290,037.45 (80,897.55) 0.0017 0.1356 0.406 0.624 0.001 0.3142 0.2503 0.5674
A2M 1,827,578,796.9 (545,505,679.48) 1,778,523,439.16 (433,650,399.82) 1,981,649,902.93 (624,365,511.97) 0.1339 0.6535 0.4509 0.2519 0.0359 0.6007 0.0396 0.1643
B2M 2,449,111.13 (900,460.4) 2,776,486.26 (1,441,411.42) 2,869,544.1 (1,083,739.71) 5.85E−05 0.1774 0.1267 0.4804 4.51E−05 0.1172 0.25 0.5588
fVII 859,473.47 (211,784.3) 828,173.72 (239,319.27) 920,802.51 (236,389.85) 0.4943 0.5917 0.3422 0.3441 0.2094 0.4345 0.1037 0.0791
Adipo 76,652,983.41 (42,470,109.59) 95,692,502.42 (128,009,842.11) 91,388,867.36 (48,296,710.64) 0.0017 0.2182 0.4015 0.358 4.92E−05 0.0149 0.0003 0.0246
ApoJ 35,855,560.96 (6,862,794.16) 36,925,546.32 (7,663,254.78) 39,890,373.94 (8,623,166.76) 0.0027 0.0448 0.6585 0.752 0.001 0.0456 0.0799 0.0771

Abbreviations: HC, healthy control; MCI, mild cognitive impairment; AD, Alzheimer's disease; SD, standard deviation; TPO, thrombopoietin; IL-18, interleukin-18; FABP3, fatty acid binding protein; PPY, pancreatic polypeptide Y; I309, chemokine I309; SAA, serum amyloid A; CRP, C-reactive protein; sVCAM, soluble vascular adhesion molecule; sICAM, soluble intercellular adhesion molecule; A2M, alpha-2-macroglobulin; B2M, beta-2 microglobulin; FVII, Factor VII; adipo, adiponectin; apoJ, apolipoprotein J.